Lipo-C
Lipotropic / MIC+B12 blend
Lipo-C (Lipotropic / MIC+B12 blend) is a metabolic & fat loss research compound. Methionine-inositol-choline plus B12 — supports fat metabolism and liver fat handling.
Lipo-C quick facts
| Reported research dose | .5ml-1ml |
| Route | Either |
| Frequency | 1x Daily Pre Exercise · Daily ( On Workout Days) |
| Half-life | Varies by component |
| Forms | Injectable |
| Evidence level | Anecdotal + supplement |
Fat-loss support shot, best pre-exercise. A helper, not a driver.
How Lipo-C works
Methionine-inositol-choline plus B12 — supports fat metabolism and liver fat handling.
Proposed benefits
Researched for fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
✅ Clinically validated
- No randomised trial of the combination for fat loss. The individual components have real but separate literatures: B12 has unambiguous evidence in deficiency and none for fat loss in replete people; choline is an essential nutrient with evidence in hepatic steatosis; inositol has trial data in PCOS-related insulin resistance.
- A lipotropic injection has never been shown in a controlled trial to cause fat loss, and that is the honest headline.
📊 Correlative data
- Very widely administered in clinics, usually alongside a calorie deficit and often alongside a GLP-1 — which makes attribution nearly impossible, since the intervention it accompanies is one that reliably causes weight loss on its own.
- Well tolerated. Reported energy improvement is real and most likely explained by the B12 in anyone who was actually low.
🧪 Theoretical / extrapolated
- Methionine, inositol and choline plus B12. Methionine and choline are methyl donors required for phosphatidylcholine synthesis, which the liver needs to package and export fat as VLDL — choline deficiency causes hepatic steatosis in humans, so the liver mechanism is real.
- Supporting fat export from the liver is not the same as burning fat from the body. The mechanism is coherent for hepatic fat handling and does not extend to adipose tissue, which is where the marketing takes it.
- The strongest honest use of this is correcting a genuine deficiency — which is worth testing for rather than assuming.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Lipo-C — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- A lipotropic / metabolic-cofactor blend — B-vitamins, methyl donors and carnitine in varying combinations.
- *the metabolic-cofactor arm:* These act on mitochondrial function, NAD+ availability, sirtuin signalling or cellular clearance. The honest prediction is that acute harm is unlikely and the interesting risks are theoretical and long-range — which is a different shape of risk, not an absence of one.
- *the metabolic-cofactor arm:* Growth and clearance signals cut both ways. Anything that improves the efficiency of cell survival is also improving it for cells you would rather not keep. Anything that pushes clearance hard is doing so indiscriminately.
- *the metabolic-cofactor arm:* The near-term, practical ones: NAD+ precursors and infusions commonly cause flushing and a strong sensation if pushed fast, and several compounds in this class are stimulating enough to disrupt sleep.
- The methyl-donor arm is the one to know about. If you carry an MTHFR variant, or already supplement methylfolate and B12, this adds to that pool rather than starting it — and homocysteine is the marker that reads the result.
- The risk that belongs to the blend rather than any component: double-dosing. If you already run any of the peptides above separately, adding this blend means two doses of it — and almost nobody counts a blend's arms against what is already in their protocol. Read the composition against your current stack before the first injection.
What has actually been reported
- *the metabolic-cofactor arm:* Generally well tolerated at studied doses. NAD+ infusion discomfort is rate-dependent and resolves by slowing down.
- *the metabolic-cofactor arm:* The human evidence is mostly short trials with surrogate endpoints — a marker moved, not a life changed. That is worth knowing before you build a decade-long habit on it.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- *the metabolic-cofactor arm:* Slow the infusion rate. Almost all NAD+ discomfort is rate, not dose. There is no prize for finishing quickly.
- *the metabolic-cofactor arm:* Dose earlier in the day. Several of these are subtly stimulating, and sleep is where most of the repair you are paying for happens.
- *the metabolic-cofactor arm:* Pick an endpoint you can actually measure, and take the baseline before you start. This is the class most prone to spending years on something with no way of knowing whether it did anything.
- *the metabolic-cofactor arm:* Fix the basics first. Sleep, training and bloodwork move the same markers further than anything on this list, and they are free. A longevity compound stacked on four hours of sleep is a rounding error.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- *the metabolic-cofactor arm:* There is no NAD+ assay worth ordering clinically. Judge this class on downstream markers — inflammatory markers, lipids, fasting glucose, and whatever your baseline panel showed as out of range.
Don't run this if
- *the metabolic-cofactor arm:* Active malignancy, for the survival-signalling reasoning above.
- *the metabolic-cofactor arm:* Pregnancy — uncharacterised.
The honest unknown
- *the metabolic-cofactor arm:* Whether any of it extends healthspan in humans. Every honest person in this field is running on mechanism and animal data, and this catalogue should say so rather than imply otherwise.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Lipo-C
Buy Lipo-C at Disguised Alpha →Lipo-C — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Lipo-C moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
From the the lipotropic arm arm. Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
From the the lipotropic arm arm. Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
From the the lipotropic arm arm. Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Lipo-C — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →A lipotropic / metabolic-cofactor blend — B-vitamins, methyl donors and carnitine in various combinations. The methyl-donor arm is the one worth knowing about: if you carry an MTHFR variant or are already supplementing methylfolate and B12, you are adding to that pool rather than starting it, and homocysteine is the marker that reads the result.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for Lipo-C — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Lipo-C
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| HbA1c (Hemoglobin A1c) | Where you started, so you can prove the change was real |
| Fasting Insulin | Moves years before HbA1c does — the earliest signal you get |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Rapid fat loss shifts triglycerides fast, in both directions |
| Comprehensive Metabolic Panel (CMP) | Liver, kidney and electrolytes while intake is restricted |
The Metabolic Health & Prediabetes panel covers these in one order — 8 markers, $81.45 with the discount applied.
Check results you already have → · All 102 markers A–Z
Lipo-C — frequently asked questions
What is Lipo-C?
Lipo-C (Lipotropic / MIC+B12 blend) is a metabolic & fat loss research compound. Methionine-inositol-choline plus B12 — supports fat metabolism and liver fat handling.
Is the full Lipo-C protocol on this page?
The reported research dose is on this page, along with how Lipo-C works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Lipo-C?
Lipo-C has an approximate half-life of Varies by component, which is part of what determines how often it's dosed.
What's the evidence behind Lipo-C?
Current evidence level: Anecdotal + supplement. Lipo-C is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Lipo-C protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Lipo-C is used for
Lipo-C appears under 2 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.